- Home
- PMCB vs SMTK Comparison
PMCB vs SMTK Comparison
Compare PMCB & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SMTK
- Stock Information
- Founded
- PMCB 1996
- SMTK 2009
- Country
- PMCB United States
- SMTK United Kingdom
- Employees
- PMCB N/A
- SMTK N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SMTK
- Sector
- PMCB Health Care
- SMTK
- Exchange
- PMCB Nasdaq
- SMTK NYSE
- Market Cap
- PMCB 7.6M
- SMTK 6.1M
- IPO Year
- PMCB N/A
- SMTK N/A
- Fundamental
- Price
- PMCB $1.05
- SMTK $0.93
- Analyst Decision
- PMCB
- SMTK
- Analyst Count
- PMCB 0
- SMTK 0
- Target Price
- PMCB N/A
- SMTK N/A
- AVG Volume (30 Days)
- PMCB 8.5K
- SMTK 150.8K
- Earning Date
- PMCB 08-12-2025
- SMTK 08-11-2025
- Dividend Yield
- PMCB N/A
- SMTK N/A
- EPS Growth
- PMCB N/A
- SMTK N/A
- EPS
- PMCB 1.29
- SMTK N/A
- Revenue
- PMCB N/A
- SMTK $105,000.00
- Revenue This Year
- PMCB N/A
- SMTK N/A
- Revenue Next Year
- PMCB N/A
- SMTK N/A
- P/E Ratio
- PMCB $0.82
- SMTK N/A
- Revenue Growth
- PMCB N/A
- SMTK 854.54
- 52 Week Low
- PMCB $1.00
- SMTK $0.78
- 52 Week High
- PMCB $2.42
- SMTK $7.80
- Technical
- Relative Strength Index (RSI)
- PMCB 47.26
- SMTK N/A
- Support Level
- PMCB $1.00
- SMTK N/A
- Resistance Level
- PMCB $1.07
- SMTK N/A
- Average True Range (ATR)
- PMCB 0.05
- SMTK 0.00
- MACD
- PMCB 0.01
- SMTK 0.00
- Stochastic Oscillator
- PMCB 39.78
- SMTK 0.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in several applications, including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.